Gold prices edge higher on raised Fed rate cut hopes
Philip Morris International Inc. (NYSE:PM) shares soared to an all-time high, reaching a price level of $176.68. With a substantial market capitalization of $276 billion, this milestone underscores the company’s robust performance amidst a challenging market environment. According to InvestingPro analysis, the stock appears to be trading above its Fair Value. Over the past year, the tobacco giant has witnessed a remarkable surge in its stock value, with a total return of 83.74% and a strong year-to-date gain of 46.89%. Investors have shown increased confidence in Philip Morris’s strategic initiatives and its ability to navigate through regulatory pressures and shifting consumer habits. InvestingPro subscribers can access 12 additional key insights about PM’s performance and outlook. The all-time high represents a significant achievement for the company, reflecting its sustained growth trajectory and strong market position. The company has maintained dividend payments for 18 consecutive years, currently offering a 3.08% yield, with analysts setting price targets ranging from $143.45 to $205.
In other recent news, Philip Morris International Inc. reported a strong first quarter, with earnings per share exceeding expectations by 6%. The company also raised its full-year 2025 EPS guidance, influenced by favorable foreign exchange rates. Following these results, UBS upgraded Philip Morris’s stock rating to Neutral from Sell, increasing the price target to $170. Stifel analysts also raised their price target to $186, maintaining a Buy rating, citing significant organic revenue and profit growth. Philip Morris issued $2.5 billion in new notes across four tranches, intended for general corporate purposes such as debt refinancing. The company held its Annual Meeting of Shareholders, where all nominated directors were elected, and PricewaterhouseCoopers was ratified as the independent auditor. Meanwhile, the U.S. FDA and CBP seized nearly two million units of unauthorized e-cigarette products in Chicago, valued at $33.8 million, as part of efforts to prevent illegal e-cigarettes from entering the U.S. The seized products violated the FDA’s Federal Food, Drug, and Cosmetic Act and lacked mandatory premarket authorization orders.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.